L-Alanyl-L-Glutamine PCD Pharma Franchise Company

Cafoli Lifecare offers an L-Alanyl-L-Glutamine PCD pharma franchise for distributors serving hospitals, nursing homes and critical care institutions. Our range currently comprises 1 injection formulation, manufactured at WHO-GMP certified facilities under strict sterile conditions and supplied with complete quality documentation and monopoly distribution rights.

What is L-Alanyl-L-Glutamine?

L-Alanyl-L-Glutamine is a synthetic dipeptide of the amino acids L-alanine and L-glutamine, developed to solve a specific pharmaceutical problem: free glutamine is poorly soluble and unstable in aqueous solution, so it cannot be included in conventional parenteral nutrition bags. The dipeptide form is highly soluble and heat-stable, and once infused it is rapidly hydrolysed in plasma by peptidases to release free alanine and glutamine. This matters clinically because glutamine becomes a conditionally essential amino acid in catabolic states — it is the primary fuel of enterocytes and rapidly dividing immune cells and supports gut barrier integrity. See PubChem: Alanylglutamine for the compound profile.

Therapeutic Applications of L-Alanyl-L-Glutamine

The injection is used as a glutamine-supplying component of parenteral nutrition regimens in patients who are hypercatabolic or unable to meet nutritional requirements enterally — typically following major surgery, severe trauma or burns, and in selected intensive care patients. It is administered as an addition to a complete parenteral nutrition regimen, never as a stand-alone infusion, and is always diluted and given according to the prescribing clinician's protocol.

This is a prescription-only, hospital-administered product. Prescribing is led by intensivists and critical care specialists, surgeons, anaesthesiologists and clinical nutrition teams, and it must be dispensed only against a valid prescription to institutions equipped to administer parenteral nutrition.

Why L-Alanyl-L-Glutamine is a High-Potential Molecule for Distributors

This molecule behaves quite differently from a retail line, and that is exactly its appeal. Demand comes from hospitals, ICUs, surgical units and nursing homes rather than the chemist counter, which means orders are institutional, planned and repeat — a hospital with a functioning ICU consumes parenteral nutrition components continuously rather than seasonally. India's critical care and private hospital capacity has expanded substantially, and clinical nutrition has moved from an afterthought to a routine part of ICU protocols. For a distributor, a specialised injectable like this is a credential: it opens the door to hospital purchase committees and pharmacy stores, and once that supply relationship exists, the wider critical care and injectable catalogue can follow through the same channel. Competition is also thinner here, because most PCD franchise partners never build a sterile injectable or clinical nutrition line at all.

Why Choose Cafoli Lifecare for Your Critical Care Franchise

Cafoli Lifecare grants monopoly distribution rights on a district or territory basis, manufactures at WHO-GMP certified facilities and supplies DCGI-approved products. Franchise partners receive complete promotional inputs including visual aids, product cards, MR bags and prescription pads, backed by transparent pricing and reliable dispatch. Over 1000+ franchise partners across India already distribute with us.

References

1. PubChem Compound Summary – Alanylglutamine
2. PubMed – Alanyl-glutamine dipeptide in parenteral nutrition
3. MedlinePlus – Nutritional Support